AACR Annual Meeting 2025

The AACR Annual Meeting 2025 took place April 25-30 in Chicago, Illinois, and featured the latest advances in cancer science and medicine.

Non-Hispanic Black women had the highest odds for hypertensive disorders of pregnancy, preterm birth, and fetal death.

Phase 1b data suggest that continuous low-dose lenalidomide improves the therapeutic index in patients RRMM.

ISB 2001, a novel BCMA-targeting trispecific antibody, showed increased expression of T-cell activation cell surface markers.

A QSP model of ISB 2001, a novel trispecific antibody, offers an effective pathway for designing phase 1 studies.

$CD47, CD20-Targeting Bispecific Fusion Protein Evaluated for Refractory NHL in First-in-Human Trial$

Efficacy and safety profile data were presented at the AACR Annual Meeting 2025.

CR1-02 was well-tolerated and led to stable disease in patients with relapsed or refractory AML.